THE ROLE OF NHS ENGLAND COMMISSIONING POLICIES IN PROMOTING EQUITABLE ACCESS TO HIGH-COST DRUGS

被引：0
|
作者：
Anderson, Marina [1 ]
机构：
[1] Univ Liverpool, Univ Hosp Aintree, Dept Rheumatol, Liverpool L69 3BX, Merseyside, England
来源：
RHEUMATOLOGY | 2015年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
I69
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [41] Barriers to access to insulin pumps in Chile: A qualitative study of a high-cost technology
    Cabieses, Baltica
    Obach, Alexandra
    Madrid, Paula
    Paredes, Daniela
    HEALTH POLICY AND TECHNOLOGY, 2025, 14 (02)
  • [42] Distinguishing moral hazard from access for high-cost healthcare under insurance
    Robertson, Christopher T.
    Yuan, Andy
    Zhang, Wendan
    Joiner, Keith
    PLOS ONE, 2020, 15 (04):
  • [43] Evaluation of access to high-cost medicines in Australia using national claims data
    Lu, CY
    Williams, K
    Day, R
    VALUE IN HEALTH, 2005, 8 (06) : A28 - A28
  • [44] ASSESSMENT OF PATIENT SATISFACTION WITH PUBLIC PHARMACIES DISPENSING HIGH-COST DRUGS IN GREECE
    Georgi, C.
    Georgis, V
    Karakolias, S.
    VALUE IN HEALTH, 2023, 26 (12) : S308 - S309
  • [45] Senator Urges VA to "Break" Patents for High-Cost Hepatitis C Drugs
    Buchholz, Laura
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (02): : 115 - 115
  • [46] A clinical audit of high-cost approved drugs in dermatology: 2003-2013
    Ong, N.
    McMeniman, E.
    Soyer, H. P.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 : 58 - 59
  • [47] Serious adverse events with high-cost drugs accessed through litigation in Brazil
    da Silva, Ricardo Eccard
    Lima, Elisangela da Costa
    Novaes, Maria Rita C. G.
    Serpa Osorio-de-Castro, Claudia Garcia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 159 - 159
  • [48] Coverage for High-Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D
    Yazdany, Jinoos
    Dudley, R. Adams
    Chen, Randi
    Lin, Grace A.
    Tseng, Chien-Wen
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (06) : 1474 - 1480
  • [49] Off-Label Use of "High-cost'' drugs in Paris area hospitals
    Kabiche, S.
    Monzat, D.
    Le Jouan, M.
    Farinotti, R.
    Montagnier-Petrissans, C.
    Le Gonidec, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1261 - 1261
  • [50] High-Cost Drugs: Understanding the Management and Failures of Dispensation in Five Brazilian States
    Aquino, Simone
    Zago Novaretti, Marcia Cristina
    ADMINISTRACAO PUBLICA E GESTAO SOCIAL, 2015, 7 (03): : 138 - 147
12345